Embryonic proteins reactivated in lung tumors may drive faster growth

Researchers have uncovered how proteins normally active only before birth can drive aggressive lung cancer, opening new avenues for future treatments. The study found that more aggressive lung cancers switch on a pair of embryonic proteins (proteins not usually found in healthy adult cells), resulting in poorer patient outcomes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup